HIV infection and bone mineral density in middle-aged women

被引:103
作者
Arnsten, JH
Freeman, R
Howard, AA
Floris-Moore, M
Santoro, N
Schoenbaum, EE
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA
关键词
D O I
10.1086/501015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Osteopenia is prevalent in persons with human immunodeficiency virus ( HIV) infection and is part of a normal sequence of aging in women. Most studies of bone mineral density ( BMD) and HIV infection have focused on men or have lacked a comparison group of individuals without HIV infection with similar behavioral risk factors. Methods. We analyzed BMD in 495 middle-aged women ( defined as women >= 40 years of age); 263 women had HIV infection, and 232 women were HIV-negative with behavioral risk factors similar to those of the HIV-positive group. Results. The median age of the women in the study was 44 years, 54% were black, and 92% had used illicit drugs. Femoral neck BMD and lumbar spine BMD were reduced in women with HIV infection, compared with women without HIV infection ( femoral neck BMD, g/cm(2) vs. g/cm(2);; lumbar 1.01 +/- 0.13 1.05 +/- 0.13 Pp. 001 spine BMD, g/cm(2) vs. g/cm(2);). In addition to HIV infection, other factors independently 1.21 +/- 0.17 1.24 +/- 0.17 P = .04 dependently associated with lower BMD in both sites were being older, not being black, and having a low body weight. In race-stratified multivariate analyses, HIV infection was associated with BMD only in non-black women. Among HIV-positive women, 84% had taken antiretrovirals, and 62% had taken protease inhibitors, but their use was not associated with BMD. Methadone treatment was also independently associated with reduced lumbar spine BMD. Conclusion. Middle-aged women with HIV infection have reduced BMD, compared with women at similar risk for HIV infection, independent of antiretroviral use. Among HIV-positive women, those who are not black, who are underweight, and who use opiates may be at particular risk. Although the prevalence of reduced BMD in this cohort was higher among women with HIV infection than among those without ( 27% vs. 19%), the overall prevalence of reduced BMD was low, compared with national estimates and with previous studies involving HIVpositive women and men.
引用
收藏
页码:1014 / 1020
页数:7
相关论文
共 36 条
[1]   BMD is reduced in HIV-infected men irrespective of treatment [J].
Amiel, C ;
Ostertag, A ;
Slama, L ;
Baudoin, C ;
N'Guyen, T ;
Lajeunie, E ;
Neit-Ngeilh, L ;
Rozenbaum, W ;
De Vernejoul, MC .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (03) :402-409
[2]   Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection:: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy [J].
Aukrust, P ;
Haug, CJ ;
Ueland, T ;
Lien, E ;
Müller, F ;
Espevik, T ;
Bollerslev, J ;
Froland, SS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :145-150
[3]  
Avis Nancy E., 1994, Annals of Epidemiology, V4, P214
[4]   Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia [J].
Brown, TT ;
Ruppe, MD ;
Kassner, R ;
Kumar, P ;
Kehoe, T ;
Dobs, AS ;
Timpone, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) :1200-1206
[5]   Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy [J].
Bruera, D ;
Luna, N ;
David, DO ;
Bergoglio, LA ;
Zamudio, J .
AIDS, 2003, 17 (13) :1917-1923
[6]   Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy [J].
Carr, A ;
Miller, J ;
Eisman, JA ;
Cooper, DA .
AIDS, 2001, 15 (06) :703-709
[7]   Testosterone replacement treatment options for HIV-infected men [J].
Cofrancesco, J ;
Whalen, JJ ;
Dobs, AS .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 16 (04) :254-265
[8]   Opiate drug use: A potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease [J].
Cooper, OB ;
Brown, TT ;
Dobs, AS .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S132-S136
[9]   EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES [J].
CUMMINGS, SR ;
KELSEY, JL ;
NEVITT, MC ;
ODOWD, KJ .
EPIDEMIOLOGIC REVIEWS, 1985, 7 :178-208
[10]   Reduced bone density in HIV-infected women [J].
Dolan, SE ;
Huang, JS ;
Killilea, KM ;
Sullivan, MP ;
Aliabadi, N ;
Grinspoon, S .
AIDS, 2004, 18 (03) :475-483